Comprehensive evaluation of positional candidates in the IL-18 pathway reveals suggestive associations with schizophrenia and herpes virus seropositivity

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 3, 2008, Pages 343-350

  Shirts, Brian H ^a,b   Wood, Joel ^a   Yolken, Robert H ^c   Nimgaonkar, Vishwajit L ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Genetic association; HSV1; IL18 RAP; IL18R1; Interleukin 12

Indexed keywords

INTERLEUKIN 18;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HERPES SIMPLEX VIRUS 1; HERPES VIRUS; HUMAN; IL12A GENE; IL12B GENE; IL18 GENE; IL18BP GENE; IL18R1 GENE; IL18RAP GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIBODIES, VIRAL; HAPLOTYPES; HUMANS; INTERLEUKIN-18; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SIMPLEXVIRUS;

HERPESVIRIDAE; HUMAN HERPESVIRUS 1;

EID: 42149114046     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30603     Document Type: Article

References (70)

1. Akira S. 2000. The role of IL-18 in innate immunity. Curr Opin Immunol 12(1):59-63.
2. Akiyama K. 1999. Serum levels of soluble IL-2 receptor alpha, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration. Schizophr Res 37(1):97-106.
3. Armitage P. 1955. Tests for linear trends in proportions and frequencies. Biometrics 11:375-386.
4. Babulas V, Factor-Litvak P, Goetz R, Schaefer CA, Brown AS. 2006. Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia. Am J Psychiatry 163(5):927-929.
5. Bacanu SA, Devlin B, Roeder K. 2000. The Power of Genomic Control. Am J Hum Genet 66(6):1933-1944.
6. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263-265. Epub 2004 Aug 05.
7. Brown AS. 2006. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull 32(2):200-202.
8. Burkovetskaya ME, Levin SG, Godukhin OV. 2007. Neuroprotective effects of interleukin-10 and tumor necrosis factor-alpha against hypoxia-induced hyperexcitability in hippocampal slice neurons. Neurosci Lett 416(3):236-240.
9. Cannon TD, Kaprio J, Lonnqvist J, Huttunen M, Koskenvuo M. 1998. The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study Arch Gen Psychiatry 55(1):67-74.
10. Cannon TD, van Erp TG, Rosso IM, Huttunen M, Lonnqvist J, Pirkola T, Salonen O, Valanne L, Poutanen VP, Standertskjold-Nordenstam CG. 2002. Fetal hypoxia and structural brain abnormalities in schizophrenic patients, their siblings, and controls. Arch Gen Psychiatry 59(1):35-41.
11. Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR, Davies NJ, Venturi P, Jones LA, Lewis SW, Sham PC, et al. 1999. Heritability estimates for psychotic disorders: The Maudsley twin psychosis series. Arch Gen Psychiatry 56(2):162-168. 18: Filbey FM et al. Negative symptoms of familial...[PMID: 9988837] related articles, links.
12. Clarke MC, Harley M, Cannon M. 2006. The role of obstetric events in schizophrenia. Schizophr Bull 32(1):3-8.
13. ContiB, Park LC, Calingasan NY, Kim Y, Kim H, Bae Y, Gibson GE, Joh TH. 1999. Cultures of astrocytes and microglia express interleukin 18. Brain Res Mol Brain Res 67(1):46-52.
14. Dalman C, Thomas HV, David AS, Gentz J, Lewis G, Allebeck P. 2001. Signs of asphyxia at birth and risk of schizophrenia. Population-based case-control study. Br J Psychiatry 179:403-408.
15. Devlin B, Roeder K. 1999. Genomic control for association studies. Biometrics 55:997-1004.
16. Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25(2):115-121.
17. Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E, Mortensen PB. 2006. Association of schizophrenia and autoimmune diseases: Linkage of Danish national registers. Am J Psychiatry 163(3):521-528.
18. Felderhoff-Mueser U, Schmidt OI, Oberholzer A, Buhrer C, Stahel PF. 2005. IL-18: A key player in neuroinflammation and neurodegeneration? Trends Neurosci 28(9):487-493.
19. Felderhoff-Mueser U, Sifringer M, Polley O, Dzietko M, Leineweber B, Mahler L, Baier M, Bittigau P, Obladen M, Ikonomidou C, et al. 2005. Caspase- 1-processed interleukins in hyperoxia-induced cell death in the developing brain. Ann Neurol 57(1):50-59.
20. Fujioka N, Akazawa R, Ohashi K, Fujii M, Ikeda M, Kurimoto M. 1999. Interleukin-18 protects mice against acute herpes simplex virus type 1 infection. J Virol 73(3):2401-2409.
21. Gatto NM, Campbell UB, Rundle AG, Ahsan H. 2004. Further development of the case-only design for assessing gene-environment interaction: Evaluation of and adjustment for bias. Int J Epidemiol 33(5):1014-1024.
22. Gracie JA, Robertson SE, McInnes IB. 2003. Interleukin-1. J Leukoc Biol 73(2):213-224.
23. Hedtjarn M, Mallard C, Arvidsson P, Hagberg H. 2005. White matter injury in the immature brain: Role of interleukin-18. Neurosci Lett 373(1):16-20.
24. Hedtjarn M, Mallard C, Iwakura Y, Hagberg H. 2005. Combined deficiency of IL-1beta18, but not IL-1alphabeta, reduces susceptibility to hypoxia-ischemia in the immature brain. Dev Neurosci 27(2-4):143-148.
25. Hurme M, Haanpaa M, Nurmikko T, Wang XY, Virta M, Pessi T, Kilpinen S, Hulkkonen J, Helminen M. 2003. IL-10 gene polymorphism and herpesvirus infections. J Med Virol 70(1):S48-S50.
26. Jones PB, Rantakallio P, Hartikainen AL, Isohanni M, Sipila P. 1998. Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: A 28-year follow-up of the 1966 north Finland general population birth cohort. Am J Psychiatry 155(3):355-364.
27. Kato C, Petronis A, Okazaki Y, Tochigi M, Umekage T, Sasaki T. 2002. Molecular genetic studies of schizophrenia: Challenges and insights. Neurosci Res 43(4):295-304.
28. Kendall G, Peebles D. 2005. Acute fetal hypoxia: The modulating effect of infection. Early Hum Dev 81(1):27-34. Epub 2004 Nov 19.
29. Kim YK, Suh IB, Kim H, Han CS, Lim CS, Choi SH, Licinio J. 2002. The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs. Mol Psychiatry 7(10):1107-1114.
30. Kim YK, Myint AM, Lee BH, Han CS, Lee HJ, Kim DJ, Leonard BE. 2004. Th1, Th2 and Th3 cytokine alteration in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 28(7):1129-1134.
31. Lee S, Gierynska M, Eo SK, Kuklin N, Rouse BT. 2003. Influence of DNA encoding cytokines on systemic and mucosal immunity following genetic vaccination against herpes simplex virus. Microbes Infect 5(7):571-578.
32. Leweke FM, Gerth CW, Koethe D, Klosterkotter J, Ruslanova I, Krivogorsky B, Torrey EF, Yolken RH. 2004. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 254(1):4-8.
33. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, et al. 2003. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 73(1):34-48.
34. Liu B, Mori I, Hossain MJ, Dong L, Takeda K, Kimura Y. 2004. Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity. J Gen Virol 85(Pt 2):423-428.
35. Lu LX, Guo SQ, Chen W, Li Q, Cheng J, Guo JH. 2004. Effect of clozapine and risperidone on serum cytokine levels in patients with first-episode paranoid schizophrenia. Di Yi Jun Yi Da Xue Xue Bao 24(11):1251-1254.
36. Mori I, Hossain MJ, Takeda K, Okamura H, Imai Y, Kohsaka S, Kimura Y. 2001. Impaired microglial activation in the brain of IL-18-gene-disrupted mice after neurovirulent influenza A virus infection. Virology 287(1):163-170.
37. Muller N, Riedel M, Ackenheil M, Schwarz MJ. 1999. The role of immune function in schizophrenia: An overview. Eur Arch Psychiatry Clin Neurosci 4:62-68.
38. Mundo E, Altamura AC, Vismara S, Zanardini R, Bignotti S, Randazzo R, Montresor C, Gennarelli M. 2005. MCP-1 gene (SCYA2) and schizophrenia: A case-control association study. Am J Med Genet Part B 132B(1):1-4.
39. Murray RM, Jones PB, Susser E, Van Os J, Cannon M. editors. 2003. The epidemiology of schizophrenia 1st edition. Cambridge, UK: Cambridge University Press. pp 454.
40. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H. 2001. Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19:423-474.
41. Owen MJ, Williams NM, O'Donovan MC. 2004. The molecular genetics of schizophrenia: New findings promise new insights. Mol Psychiatry 9(1):14-27.
42. Pearce BD. 2001. Schizophrenia and viral infection during neurodevelopment: A focus on mechanisms. Mol Psychiatry 6(6):634-646.
43. Petronis A. 2004. The origin of schizophrenia: Genetic thesis, epigenetic antithesis, and resolving synthesis. Biol Psychiatry 55(10):965-970.
44. Prinz M, Hanisch UK. 1999. Murine microglial cells produce and respond to interleukin-18. J Neurochem 72(5):2215-2218.
45. Rapaport MH, Delrahim KK 2001. An abbreviated review of immune abnormalities in schizophrenia. CNS Spectr 6(5):392-397.
46. Rapoport JL, Addington AM, Frangou S, Psych MR. 2005. The neurodevelopmental model of schizophrenia: Update 2005. Mol Psychiatry 10(5):434-449.
47. Raymond M, Rousset F. 1995. GENEPOP (version 1.2): Population genetics software for exact tests and ecumenicism. J Hered 86:248-249.
48. Reddy P. 2004. Interleukin-18: Recent advances. Curr Opin Hematol 11(6):405-410.
49. Riedel M, Spellmann I, Schwarz MJ, Strassnig M, Sikorski C, Moller HJ, Muller N. 2006. Decreased T cellular immune response in schizophrenic patients. J Psychiatr Res 21:21.
50. Rinaldo A, Bacanu SA, Devlin B, Sonpar V, Wasserman L, Roeder K. 2005. Characterization of multilocus linkage disequilibrium. Genet Epidemiol 28:193-206.
51. Risch N. 1990. Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 46(2):222-228.
52. Robinson DS, O'Garra A. 2002. Further checkpoints in Th1 development. Immunity 16(6):755-758.
53. Roeder K, Bacanu SA, Sonpar V, Zhang X, Devlin B. 2005. Analysis of single-locus tests to detect gene/disease associations. Genet Epidemiol 28(3):207-219.
54. Rothermundt M, Arolt V, Bayer TA. 2001. Review of immunological and immunopathological findings in schizophrenia. Brain Behav Immun 15(4):319-339.
55. Saiki O, Uda H, Nishimoto N, Miwa T, Mima T, Ogawara T, Azuma N, Katada Y, Sawaki J, Tsutsui H, et al. 2004. Adult Still's disease reflects a Th2 rather than a Th1 cytokine profile. Clin Immunol 112(1):120-125.
56. Schwarz MJ, Chiang S, Muller N, Ackenheil M. 2001. T-helper-1 and T-helper-2 responses in psychiatric disorders. Brain Behav Immun 15(4):340-370.
57. Schwarz MJ, Kronig H, Riedel M, Dehning S, Douhet A, Spellmann I, Ackenheil M, Moller HJ, Muller N. 2006. IL-2 and IL-4 polymorphisms as candidate genes in schizophrenia. Eur Arch Psychiatry Clin Neurosci 256(2):72-76.
58. Shen R, Fan JB, Campbell D, Chang W, Chen J, Doucet D, Yeakley J, Bibikova M, Wickham Garcia E, McBride C, et al. 2005. High-throughput SNP genotyping on universal bead arrays. Mutat Res 573(1-2):70-82.
59. Shi FD, Takeda K, Akira S, Sarvetnick N, Ljunggren HG. 2000. IL-18 directs autoreactive T cells and promotes autodestruction in the central nervous system via induction of IFN-gamma by NK cells. J Immunol 165(6):3099-3104.
60. Shirts BH, Bamne M, Kim JJ, Talkowski M, Wood J, Yolken R, Nimgaonkar VL. 2006. A comprehensive genetic association and functional study of TNF in schizophrenia risk. Schizophr Res 83(1):7-13.
61. Shirts BH, Wood J, Yolken RH, Nimgaonkar VL. 2006. Association study of IL10, IL1β, and IL1RN and schizophrenia using tag SNPs from a comprehensive database: Suggestive association with rs16944 at IL1β. Schizophr Res 88(1-3):235-244.
62. Sugama S, Wirz SA, Barr AM, Conti B, Bartfai T, Shibasaki T. 2004. Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine treatment. Neuroscience 128(2):451-458.
63. Tanaka KF, Shintani F, Fujii Y, Yagi G, Asai M. 2000. Serum interleukin-18 levels are elevated in schizophrenia. Psychiatry Res 96(1):75-80.
64. Ueda T, Takeyama Y, Yasuda T, Matsumura N, Sawa H, Nakajima T, Ajiki T, Fujino Y, Suzuki Y, Kuroda Y. 2006. Significant elevation of serum interleukin-18 levels in patients with acute pancreatitis. J Gastroenterol 41(2):158-165.
65. Ugwumadu A. 2006. Infection and fetal neurologic injury. Curr Opin Obstet Gynecol 18(2):106-111.
66. Van Erp TG, Saleh PA, Rosso IM, Huttunen M, Lonnqvist J, Pirkola T, Salonen O, Valanne L, Poutanen VP, Standertskjold-Nordenstam CG, et al. 2002. Contributions of genetic risk and fetal hypoxia to hippocampal volume in patients with schizophrenia or schizoaffective disorder, their unaffected siblings, and healthy unrelated volunteers. Am J Psychiatry 159(9):1514-1520.
67. Yamada K, Iwayama-Shigeno Y, Yoshida Y, Toyota T, Itokawa M, Hattori E, Shimizu H, Yoshikawa T. 2004. Family-based association study of schizophrenia with 444 markers and analysis of a new susceptibility locus mapped to llql3.3. Am J Med Genet Part B 127B(1):11-19.
68. Yolken R. 2004. Viruses and schizophrenia: A focus on herpes simplex virus. Herpes 11(2):83A-88A.
69. Zhu M, Xu X, Liu H, Liu X, Wang S, Dong F, Yang B, Song G. 2003. Enhancement of DNA vaccine potency against herpes simplex virus 1 by co-administration of an interleukin-18 expression plasmid as a genetic adjuvant. J Med Microbiol 52(Pt 3):223-228.
70. Zintzaras E, Ioannidis JP. 2005. Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol 28(2):123-137.